Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.

Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):6385-8. doi: 10.1128/AAC.01604-13. Epub 2013 Sep 30.

2.

Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.

Olesen B, Frimodt-Møller J, Leihof RF, Struve C, Johnston B, Hansen DS, Scheutz F, Krogfelt KA, Kuskowski MA, Clabots C, Johnson JR.

Antimicrob Agents Chemother. 2014 Nov;58(11):6886-95. doi: 10.1128/AAC.03679-14. Epub 2014 Sep 8.

3.

Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.

Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1859-1866. doi: 10.1007/s10096-017-3021-9. Epub 2017 May 27.

PMID:
28550370
4.

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV.

mBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.

5.

The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.

Can F, Kurt-Azap Ö, İspir P, Nurtop E, Seref C, Loçlar İ, Aktaş ON, Orhan YC, Ergonul O.

J Glob Antimicrob Resist. 2016 Mar;4:49-52. doi: 10.1016/j.jgar.2015.10.006. Epub 2015 Nov 14.

PMID:
27436393
6.

Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.

Drawz SM, Porter S, Kuskowski MA, Johnston B, Clabots C, Kline S, Ferrieri P, Johnson JR.

Antimicrob Agents Chemother. 2015 Sep;59(9):5331-9. doi: 10.1128/AAC.00048-15. Epub 2015 Jun 22.

7.

Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.

Peirano G, van der Bij AK, Freeman JL, Poirel L, Nordmann P, Costello M, Tchesnokova VL, Pitout JD.

Antimicrob Agents Chemother. 2014 Jul;58(7):3762-7. doi: 10.1128/AAC.02428-14. Epub 2014 Apr 21.

8.

Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.

Ranjan A, Shaik S, Hussain A, Nandanwar N, Semmler T, Jadhav S, Wieler LH, Ahmed N.

Antimicrob Agents Chemother. 2015 Oct;59(10):6087-95. doi: 10.1128/AAC.01447-15. Epub 2015 Jul 20.

9.

High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.

Ho PL, Chu YP, Lo WU, Chow KH, Law PY, Tse CW, Ng TK, Cheng VC, Que TL.

J Med Microbiol. 2015 Mar;64(Pt 3):243-7. doi: 10.1099/jmm.0.000012. Epub 2015 Jan 13.

PMID:
25587081
10.

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA; AMERECUS Investigators.

Antimicrob Agents Chemother. 2012 May;56(5):2364-70. doi: 10.1128/AAC.05824-11. Epub 2012 Feb 21.

11.

A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Banerjee R, Johnson JR.

Antimicrob Agents Chemother. 2014 Sep;58(9):4997-5004. doi: 10.1128/AAC.02824-14. Epub 2014 May 27. Review.

12.

Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.

Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S.

Antimicrob Agents Chemother. 2015;59(6):3424-32. doi: 10.1128/AAC.00270-15. Epub 2015 Mar 30.

13.

Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.

Kim SY, Park YJ, Johnson JR, Yu JK, Kim YK, Kim YS.

Diagn Microbiol Infect Dis. 2016 Feb;84(2):97-101. doi: 10.1016/j.diagmicrobio.2015.10.016. Epub 2015 Oct 28.

PMID:
26643062
14.

Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.

Dahbi G, Mora A, Mamani R, López C, Alonso MP, Marzoa J, Blanco M, Herrera A, Viso S, García-Garrote F, Tchesnokova V, Billig M, de la Cruz F, de Toro M, González-López JJ, Prats G, Chaves F, Martínez-Martínez L, López-Cerezo L, Denamur E, Blanco J.

Int J Med Microbiol. 2014 Nov;304(8):1247-57. doi: 10.1016/j.ijmm.2014.10.002. Epub 2014 Oct 14.

PMID:
25455219
15.

Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy.

Ghodousi A, Bonura C, Di Carlo P, van Leeuwen WB, Mammina C.

Int J Food Microbiol. 2016 Jul 2;228:10-3. doi: 10.1016/j.ijfoodmicro.2016.04.004. Epub 2016 Apr 6.

PMID:
27082892
16.

Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.

Sauget M, Cholley P, Vannier A, Thouverez M, Nicolas-Chanoine MH, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2016 Dec;48(6):744-747. doi: 10.1016/j.ijantimicag.2016.09.023. Epub 2016 Nov 4.

PMID:
27836379
17.

Molecular epidemiology of bloodstream-associated Escherichia coli ST131 H30-Rx subclone infection in a region with high quinolone resistance.

Can F, Kurt-Azap O, Nurtop E, Ispir P, Seref C, Ergonul O.

J Med Microbiol. 2016 Apr;65(4):306-310. doi: 10.1099/jmm.0.000224. Epub 2016 Jan 20.

PMID:
26795934
18.

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.

Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.

19.

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.

Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG.

mSphere. 2016 Nov 23;1(6). pii: e00314-16. eCollection 2016 Nov-Dec.

20.

Adhesion and invasion to epithelial cells and motility of extended-spectrum β-lactamase-producing Escherichia coli reveal ST131 superiority: a comparative in vitro study of extraintestinal pathogenic E. coli lineages.

Kondratyeva K, Wollman A, Gerlitz G, Navon-Venezia S.

J Med Microbiol. 2017 Sep;66(9):1350-1357. doi: 10.1099/jmm.0.000549. Epub 2017 Aug 22.

PMID:
28825894

Supplemental Content

Support Center